Patents by Inventor Melanie HUTTON

Melanie HUTTON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for the treatment and/or prophylaxis of associated disease
    Patent number: 10144775
    Abstract: The present invention relates to methods and compositions for the treatment and/or prophylaxis of Clostridium difficile associated disease (CD AD). In particular, the invention relates to antibodies that bind to C. difficile antigens and are capable of inhibiting C. difficile infection, at least one symptom of C. difficile associated disease, shedding of C. difficile, and C. difficile associated mortality. The compositions of the present application comprise: mammalian or avian antibodies which bind to a C. difficile Toxin B; and mammalian or avian antibodies that bind to a C. difficile vegetative cell antigen and/or a C. difficile endospore antigen.
    Type: Grant
    Filed: April 17, 2014
    Date of Patent: December 4, 2018
    Assignee: IMMURON LIMITED
    Inventors: Dena Lyras, Melanie Hutton, Bliss Cunningham, Lucy Li, Glen Carter, Julian Rood
  • METHODS AND COMPOSITIONS FOR THE TREATMENT AND/OR PROPHYLAXIS OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASE
    Publication number: 20160083457
    Abstract: The present invention relates to methods and compositions for the treatment and/or prophylaxis of Clostridium difficile associated disease (CD AD). In particular, the invention relates to antibodies that bind to C. difficile antigens and are capable of inhibiting C. difficile infection, at least one symptom of C. difficile associated disease, shedding of C. difficile, and C. difficile associated mortality. The compositions of the present application comprise: mammalian or avian antibodies which bind to a C. difficile Toxin B; and mammalian or avian antibodies that bind to a C. difficile vegetative cell antigen and/or a C. difficile endospore antigen.
    Type: Application
    Filed: April 17, 2014
    Publication date: March 24, 2016
    Applicant: IMMURON LIMITED
    Inventors: Dena LYRAS, Melanie HUTTON, Bliss CUNNINGHAM, Lucy LI, Glen CARTER, Julian ROOD